These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21762101)

  • 21. Atypical antipsychotics in bipolar depression: neurobiological basis and clinical implications.
    Brugue E; Vieta E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):275-82. PubMed ID: 16876306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible therapeutic effect of T-794, a novel reversible inhibitor of monoamine oxidase-A, on post-stroke emotional disturbances, assessed in animal models of depression.
    Kato M; Iwata H; Katayama T; Asai H; Narita H; Endo T
    Biol Pharm Bull; 1997 Apr; 20(4):349-53. PubMed ID: 9145208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VEGF and depression: a comprehensive assessment of clinical data.
    Clark-Raymond A; Halaris A
    J Psychiatr Res; 2013 Aug; 47(8):1080-7. PubMed ID: 23684549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there a role for palmitoylethanolamide in the treatment of depression?
    Coppola M; Mondola R
    Med Hypotheses; 2014 May; 82(5):507-11. PubMed ID: 24630855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Could treatment with arundic acid (ONO-2506) increase vulnerability for depression?
    Manev R; Manev H
    Med Hypotheses; 2006; 67(5):1170-2. PubMed ID: 16797859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Administration of Huperzine A exerts antidepressant-like activity in a rat model of post-stroke depression.
    Du Y; Liang H; Zhang L; Fu F
    Pharmacol Biochem Behav; 2017 Jul; 158():32-38. PubMed ID: 28583576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of glial cell line-derived neurotrophic factor in the pathogenesis and treatment of mood disorders.
    Tsybko AS; Ilchibaeva TV; Popova NK
    Rev Neurosci; 2017 Apr; 28(3):219-233. PubMed ID: 28099138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression.
    Levy MJF; Boulle F; Steinbusch HW; van den Hove DLA; Kenis G; Lanfumey L
    Psychopharmacology (Berl); 2018 Aug; 235(8):2195-2220. PubMed ID: 29961124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress and post-stroke depression: possible therapeutic role of polyphenols?
    Nabavi SF; Dean OM; Turner A; Sureda A; Daglia M; Nabavi SM
    Curr Med Chem; 2015; 22(3):343-51. PubMed ID: 25386821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spine synapse remodeling in the pathophysiology and treatment of depression.
    Duman CH; Duman RS
    Neurosci Lett; 2015 Aug; 601():20-9. PubMed ID: 25582786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hippocampal cAMP response element binding protein and antidepressant treatments].
    Chen L; Zhao YN; Dai JG; Wang ZL; Huang YF
    Sheng Li Xue Bao; 2010 Dec; 62(6):489-94. PubMed ID: 21170493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug Targets for Obesity and Depression: From Serotonin to Leptin.
    Haleem DJ
    Curr Drug Targets; 2016; 17(11):1282-91. PubMed ID: 26648065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depression and functional outcome after stroke: the effect of antidepressant therapy on functional recovery.
    Bilge C; Koçer E; Koçer A; Türk Börü U
    Eur J Phys Rehabil Med; 2008 Mar; 44(1):13-8. PubMed ID: 18385623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzodiazepines in the control of anxiety-induced depression.
    Fairhurst MM
    S Afr Med J; 1985 Oct; Suppl():29. PubMed ID: 2865823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A neurocognitive model for understanding treatment action in depression.
    Warren MB; Pringle A; Harmer CJ
    Philos Trans R Soc Lond B Biol Sci; 2015 Sep; 370(1677):20140213. PubMed ID: 26240428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can Statins Diminish Depression?
    Singh D; Lippmann S
    Prim Care Companion CNS Disord; 2018 Jan; 20(1):. PubMed ID: 29372939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants.
    Köhler S; Cierpinsky K; Kronenberg G; Adli M
    J Psychopharmacol; 2016 Jan; 30(1):13-22. PubMed ID: 26464458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adventures in the pathophysiology of brain ischemia: penumbra, gene expression, neuroprotection: the 2002 Thomas Willis Lecture.
    Ginsberg MD
    Stroke; 2003 Jan; 34(1):214-23. PubMed ID: 12511777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia.
    Zhuang Q; Dai C; Yang L; Wen H; Wang H; Jiang X; Zhang Y
    Cent Nerv Syst Agents Med Chem; 2017; 17(2):141-150. PubMed ID: 27142423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dopamine and depression: the forgotten neurotransmitter].
    Pitchot W; Scantamburlo G; Ansseau M
    Rev Med Liege; 2008; 63(5-6):378-84. PubMed ID: 18669208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.